D. E. Shaw & Co., Inc.

Position in ANAB — Anaptysbio, Inc

CIK 1009207 New York, NY

Back to ANAB Full portfolio

Position in ANAB

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$36,427,454

+$4,299,728 QoQ

Shares Held

539,666

-37.9% QoQ

Ownership

1.85%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#15

of 211 holders

Holding Since

Mar 2020

26 quarters on record

Voting authority Sole 97% Shared 0% None 3%

Common Shares in ANAB Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

D. E. Shaw & Co., Inc. holds $5,017,559,982 across 217 Biotechnology names. ANAB ranks #32 (0.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INSM	INSMED Inc	5,877,959	$626,707,987
2	ALNY	Alnylam Pharmaceuticals, Inc.	1,104,109	$332,369,932
3	EXEL	Exelixis, Inc.	5,551,747	$302,070,554
4	BBIO	BridgeBio Pharma, Inc.	3,633,007	$270,586,360
5	TGTX	Tg Therapeutics, Inc.	3,400,808	$186,840,390
6	HALO	Halozyme Therapeutics, Inc.	2,006,479	$157,047,110
7	AXSM	Axsome Therapeutics, Inc.	604,753	$148,025,391
8	PTCT	Ptc Therapeutics, Inc.	1,548,919	$126,345,322

All Filings in ANAB

Export CSV

26 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$36,427,454	539,666	-6.8%	Shares	Defined	2026-08-14
2026-03-31	$32,127,726	579,296	-13.6%	Shares	Defined	2026-05-15
2025-12-31	$32,495,561	670,288	+91.9%	Shares	Defined	2026-02-17
2025-09-30	$10,697,385	349,360	+211.0%	Shares	Defined	2025-11-14
2025-06-30	$2,494,147	112,349	-13.3%	Shares	Defined	2025-08-14
2025-03-31	$2,410,261	129,654	-34.2%	Shares	Defined	2025-05-15
2024-12-31	$2,609,705	197,107	-12.1%	Shares	Defined	2025-02-14
2024-09-30	$7,508,577	224,137	+30.7%	Shares	Defined	2024-11-14
2024-06-30	$4,296,544	171,450	-8.2%	Shares	Defined	2024-08-14
2024-03-31	$4,206,816	186,804	+16.5%	Shares	Defined	2024-05-15
2023-12-31	$3,434,182	160,326	+9.9%	Shares	Defined	2024-02-14
2023-09-30	$2,620,212	145,892	-29.1%	Shares	Defined	2023-11-14
2023-06-30	$4,185,890	205,796	-0.6%	Shares	Defined	2023-08-14
2023-03-31	$4,505,460	207,052	+18.9%	Shares	Defined	2023-05-15
2022-12-31	$5,398,395	174,198	-1.3%	Shares	Defined	2023-02-14
2022-09-30	$4,502,522	176,500	+34.6%	Shares	Defined	2022-11-14
2022-06-30	$2,662,378	131,152	-22.7%	Shares	Defined	2022-08-15
2022-03-31	$4,194,904	169,560	-20.3%	Shares	Defined	2022-05-16
2021-12-31	$7,390,674	212,681	-16.2%	Shares	Defined	2022-02-14
2021-09-30	$6,882,838	253,792	-1.9%	Shares	Defined	2021-11-15
2021-06-30	$6,706,650	258,644	-12.5%	Shares	Defined	2021-08-16
2021-03-31	$6,370,064	295,594	-47.7%	Shares	Defined	2021-05-17
2020-12-31	$12,145,858	564,925	-11.9%	Shares	Defined	2021-02-16
2020-09-30	$9,453,920	640,946	-8.4%	Shares	Defined	2020-11-16
2020-06-30	$15,632,758	699,767	+52.8%	Shares	Defined	2020-08-14
2020-03-31	$6,472,401	458,061	—	Shares	Defined	2020-05-15
No filing history on record for this holder in this stock.